FDA warns CBD businesses: Stop making medical claims – or else

Hemp Industry Daily
By Laura DrotleffApr 3, 2019, 4:26 pm276 pts
Three CBD companies received letters from the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC), warning them against making “unsubstantiated claims” about their products’ medical benefits. The companies, Advanced Spine and Pain LLC (Relievus) in Jenison, Michigan, Nutra Pure…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Chicago Police Can’t Search Vehicles Based on Smell of Raw Cannabis Under New Rules 68

Half-Year Retrospective: What Has Worked and What Hasn’t in Cannabis 68

Nebraska Medical Cannabis Commission Proposal Will ‘Destroy Patient Access,’ Advocates Say 68

Nova Scotians bought $127 worth of cannabis in 2024 as sales begin to level off 67

The PFAS Threat in Cannabis and Hemp: What You Need to Know 62

Circuit Court Ruling for Arkansas Renders Texas Governor’s Hemp Veto Argument Moot 62

World-Class Growing Solutions 59

Science, Not Politics, Must Guide Hemp’s Regulatory Future 58

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.